SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-06-007162
Filing Date
2006-07-24
Accepted
2006-07-24 08:00:17
Documents
2
Period of Report
2006-07-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. 8-K a5193347.txt 8-K 3976
2 EXHIBIT 99.1 a5193347ex99-1.txt EX-99.1 5181
  Complete submission text file 0001157523-06-007162.txt   10753
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 06975396
SIC: 2836 Biological Products, (No Diagnostic Substances)